| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 52,474 | 60,356 | 56,370 | 48,207 | | Cost of Revenue | 30,827 | 33,017 | 31,713 | 25,340 | | | Gross Profit | 21,647 | 27,339 | 24,657 | 22,867 | | | Operating Expenses | | Research Development | 6,334 | 7,421 | 5,256 | 6,448 | | Selling General and Administrative | 13,660 | 16,708 | 13,638 | 12,831 | | Non Recurring | 476 | 1,368 | 51,779 | 252 | | Others | 95 | 103 | 102 | 103 | | | | Total Operating Expenses | 20,565 | 25,600 | 70,775 | 19,634 | | | | Operating Income or Loss | 1,082 | 1,739 | (46,118) | 3,233 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 461 | 226 | 322 | (404) | | Earnings Before Interest And Taxes | 1,543 | 1,965 | (45,796) | 2,829 | | Interest Expense | 1,274 | 507 | 537 | 543 | | Income Before Tax | 269 | 1,458 | (46,333) | 2,286 | | Income Tax Expense | 95 | (477) | 330 | 827 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 174 | 1,935 | (46,663) | 1,459 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 174 | 1,935 | (46,663) | 1,459 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $174 | $1,935 | ($46,663) | $1,459 |
|
0.26% Nasdaq 
Income Statement
